|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Marc Ernstoff , Igor Puzanov, MD, MSCI, FACP , Caroline Robert, MD, PhD , Adi Diab, MDPublisher: Springer Publishing Co Inc Imprint: Springer Publishing Co Inc Weight: 0.318kg ISBN: 9780826172143ISBN 10: 0826172148 Pages: 274 Publication Date: 20 March 2019 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsForeword Introduction Part 1: Immune Checkpoint Inhibitors in the Clinic Chapter One: Overview of Anti-CTLA-4 Agents: Ipilimumab and Tremilimumab Daniel Hartman Johnson and Jianjun Gao Chapter Two: Overview of PD-1 and PD-L1 Inhibitors Nikolaos Andreatos, Shailender Bhatia, and Petros Grivas Chapter Three: Indications and Toxicities of Immune Checkpoint Inhibitor Combinations Lavinia Spain, Michael A. Postow, James Larkin, and Jeffrey Weber Part 2: Specific Immune Checkpoint Inhibitor Toxicities Chapter Four: General Principles of Immune-Related Toxicities Osama E. Rahma and Patrick A. Ott Chapter Five: Dermatological Toxicities: Rash, Mucosal Irritation, and Pruritus Jennifer Wu and Mario E. Lacouture Chapter Six: Musculoskeletal and Rheumatologic Toxicities Noha Abdel-Wahab, Clifton O. Bingham III, and Maria Suarez-Almazor Chapter Seven: Immune-Related Gastrointestinal Toxicities Hamzah Abu-Sbeih, Daniel Johnson, Yinghong Wang Chapter Eight: Pneumotoxicity Associated with Immune Checkpoint Blockades Vickie R. Shannon Chapter Nine: Immune-Related Endocrinopathies Associated with Immune Checkpoint Inhibitors Rajeev Sharma, Ha Nguyen, Ramona Dadu Chapter Ten: Neurologic Adverse Events and Neurologic Complications Haroon Ahmad, Jasmin Jo, Elizabeth Gaughan, Camilo Fadul Chapter Eleven: Cardiovascular Toxicities Related to Immune Checkpoint Inhibitors Pankit Vachhani, Igor Puzanov, Javid J. Moslehi Chapter Twelve: Renal Toxicities Associated with Immune Checkpoint Inhibitors Ala Abudayyeh, Maen Abdelrahim, Laurence Albiges Chapter Thirteen: Hematologic Toxicities of Apparent Immune-Related Origins George L. Chen, Caroline Robert, Alexander M. Lesokhin Chapter Fourteen: Ocular Toxicities Caused by Immune Dysregulation Liliya Golas and Dimitra Skondra Chapter Fifteen: Safety and Regulation of Immune Checkpoint Inhibitors in Special Patient Populations Douglas B. Johnson, Ryan Sullivan, Paolo A. Ascierto Chapter Sixteen: Cancer-Related Fatigue in Patients of Immune Checkpoint Inhibitor Therapy Eric D. Hansen, Michelle Walter, Amy A. Case Chapter Seventeen: Cost Effectiveness and Financial Toxicity in New Cancer Therapies Christine Kohn, Natalia Shcherbakova, Alberto J. MonteroReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |